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Aims SYNARR-Flash study (Monitoring of SYNcopes and/or sustained palpitations of suspected ARRhythmic origin) is an inter-
national, multicentre, observational, prospective trial designed to evaluate the role of external 4-week electrocardiogram
(ECG) monitoring in clinical work-up of unexplained syncope and/or sustained palpitations of suspected arrhythmic origin.
Methods and
results
Consecutive patients were enrolled within 1 month after unexplained syncope or palpitations (index event) after being
discharged from emergency room or hospitalization without a conclusive diagnosis. A 4-week ECG monitoring was
obtained by external high-capacity loop recorder (SpiderFlash-Tw, Sorin) storing patient-activated and auto-triggered
tracings. Diagnostic monitorings included (i) conclusive events with reoccurrence of syncope or palpitation with con-
comitant ECG recording (with/without arrhythmias) and (ii) events with asymptomatic predefined significant arrhyth-
mias (sustained supraventricular or ventricular tachycardia, advanced atrio-ventricular block, sinus bradycardia
,30 b.p.m., pauses .6 s). SYNARR-Flash study enrolled 395 patients (57.7% females, 56.9+ 18.7 years, 28.1%
with syncope, and 71.9% with palpitations) from 10 European centres. For syncope, the 4-week diagnostic yield was
24.5%, and predictors of diagnostic events were early start of recording (0–15 vs. .15 days after index event) (OR 6.2,
95% CI 1.3–29.6, P ¼ 0.021) and previous history of supraventricular arrhythmias (OR 3.6, 95% CI 1.4–9.7, P ¼ 0.018).
For palpitations, the 4-week diagnostic yield was 71.6% and predictors of diagnostic events were history of recurrent
palpitations (P, 0.001) and early start of recording (P ¼ 0.001).
Conclusion The 4-week external ECG monitoring can be considered as first-line tool in the diagnostic work-up of syncope and
palpitation. Early recorder use, history of supraventricular arrhythmia, and frequent previous events increased the
likelihood of diagnostic events during the 4-week external ECG monitoring.
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Introduction
The diagnosis of unexplained syncopal episodes and sustained palpi-
tations remains a difficult task in clinical cardiology.1 –6 Standard 24 h
Holter monitoring has a low diagnostic yield, while implantable loop
recorder (ILR) has a higher diagnostic yield, but it is expensive and
mildly invasive, making its role in diagnostic work-up of unexplained
syncope and palpitations questionable.7– 10
The utility of external prolonged electrocardiogram (ECG) moni-
toring in work-up of syncope is still undefined. The few available stud-
ies, generally single-centre and retrospective, provided conflicting
results, mainly due to heterogeneity of patient populations and devices
capabilities. In sustained palpitations, the external loop recorders
(ELRs) utility was more established.5 Earlier ELRs with relatively low-
storage capacity and brief patient-activated ECG tracings had limited
usefulness in syncope or asymptomatic arrhythmias.1,7,11–14 Recently,
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newer ELRs with auto-trigger capabilities showed 30% diagnostic
yield for syncope and 75% for palpitations.15 External ECG recorders
were also utilized to evaluate the burden of asymptomatic atrial
fibrillation (AF), as in cryptogenic transient ischaemic attacks or after
transcatheter ablation.16,17
Syncope and palpitations tend to occur in clusters, with higher re-
occurrence rate early after an event, thus an early use of long-term
ECG monitoring may increase the likelihood of clinical diagnosis.1,10
The SYNARR-Flash study (Monitoring of SYNcopes and/or sus-
tained palpitations of suspected ARRhythmic origin; clinicaltrial.gov
NCT02253134) is the first international, multicentre, prospective trial
designed to evaluate the feasibility and usefulness of external pro-
longed ECG monitoring in the early clinical work-up of unexplained
syncope and/or sustained palpitations of suspected arrhythmic origin.
Methods
Study design
At each enrolling centre, consecutive patients screened for enrolment
had to meet both the following inclusion criteria: (i) recent (within 1
month) episode of syncope or sustained palpitations (index event), after
being discharged from emergency room or hospitalization without a
conclusive diagnosis, and (ii) suspected arrhythmic origin according to
the clinical features defined in the 2009 Syncope Guidelines, including
the presence of cardiovascular disease or channelopathy, family history
of unexplained sudden death, or abnormal ECG findings.1
Syncope was defined as complete loss of consciousness with spontan-
eous recovery, while sustained palpitations as long-lasting sensation of
irregular or fast heart rhythm. Abnormal ECG findings included atrio-
ventricular conduction disorders [first-degree atrio-ventricular block
(AVB) I, second-degree AVB II type Mobitz 1, left or right ventricular bun-
dle branch block (LBBB/RBBB)], supraventricular rhythm disorders [sinus
arrest or pauses ,3 s, sinus bradycardia .40 b.p.m., sinus tachycardia
.100 b.p.m., paroxysmal AF, frequent premature atrial contractions
(PACs) (.10/min), chronic AF, paroxysmal atrial flutter/tachycardia],
and ventricular rhythm disorders [frequent premature ventricular con-
tractions (PVCs) (.10/min), couplets, non-sustained VT] (Table 1).
By study inclusion criteria, all patients were enrolled within 30 days
after the index event, after being discharged from emergency room
or hospitalization without a conclusive diagnosis. At enrolment, patient
medical history was collected, including a detailed report of the index
event (syncope or palpitation) and the history of events in the preceding
year and of the previously performed diagnostic tests.
Patients were instructed by the study nurse on how to use the re-
corder and to report symptoms in the diary. Patients had to wear the
recorder for 4 weeks, and a clinic visit was scheduled at the end of
the recording period (M1). Patients had to contact the centre if any
symptom occurred before M1 (in case an additional clinic visit was
scheduled) or if any technical problem occurred or the recording
stopped prematurely (in order to re-initiate the recording).
At M1, patients were interviewed, diaries were collected, and infor-
mation was cross-checked. Electrocardiogram data were uploaded to
the server. Clinical and device information, including events, device
acceptance, device malfunction, adverse events, and medications,
were reported in case report forms (CRFs).
The study was conducted in accordance with Guidelines for Good
Clinical Practice and Declaration of Helsinki and approved by relevant
local ethics committees. All enrolled patients provided written informed
consent to study participation.
Modality of ECG recording
At enrolment, a prolonged high-capacity ELR (SpiderFlash-Tw, Sorin
Group SRL, Saluggia, Italy—sized 75 × 50 × 19 mm, powered by lith-
ium battery) was provided to each patient. The three-wire recorder
was connected to the chest using disposable adhesive electrodes, which
the patient had to change daily. The recorder was carried in a disposable
bag placed around the neck.
Recorders store two leads ECG tracings on a high-capacity removable
digital card capable of up to 40 day monitoring. Three recording modal-
ities are available: (i) manual patient activation in case of symptoms; (ii)
automatic activation at predefined intervals; and (iii) auto-trigger activa-
tion at preselected rhythm disturbances, such as pauses or bradycardia
or supraventricular tachycardia (SVT) and ventricular tachycardia (VT).
Event classification and computation
of diagnostic yield
All ECG monitorings were reviewed by two separate investigators
(E.T.L. and A.M.) and categorized based on both patient diary and inter-
view and ECG data, as follows.
Diagnostic monitorings include the following:
† Conclusive events, when syncope or palpitations were reported and a
readable ECG recording was available at the time of symptom (inde-
pendently of the presence or absence of arrhythmias);
† Significant events, when the following predefined arrhythmias were
detected by auto-trigger function in the absence of reported symptoms:
(i) advanced AVB (third-degree AVB or second-degree AVB Mobitz type
2), sinus bradycardia (,30 b.p.m.), pauses ≥6 s; (ii) fast sustained supra-
ventricular tachycardia (SVT), AF, or flutter (AFL) (rate .180 b.p.m.,
duration .3 min); and (iii) non-sustained ventricular tachycardia
(NSVT, duration .10 s) or sustained ventricular tachycardia (.30 s).
Those arrhythmias were considered diagnostic even in the absence of
recurrent syncope according to the 2009 Syncope Guidelines.1
Non-diagnostic monitorings include the following:
† Suggestive events, when the following predefined arrhythmias were
detected by auto-trigger function, in the absence of reported symp-
toms: (i) sinus bradycardia (30–40 b.p.m.), 3–6 s pauses; (ii) brief
burst of SVT, AF, or AFL (15–180 s); and (iii) NSVT ,10 s;
What’s new?
† The early use of external 4-week electrocardiogram (ECG)
recorders in unexplained syncope of suspected arrhythmic
origin proved to be a feasible ‘stepwise’ strategy, starting
the recording as soon as possible after an event in order to
maximize the diagnostic yield of external ECG monitoring.
† In patients with unexplained syncope of suspected arrhythmic
origin, in whom prolonged ECG monitoring is considered ap-
propriate according to current guidelines, the 4-week external
ECG monitoring should be utilized as first step, while more ex-
pensive and minimally invasive implantable loop recorder (ILR)
should be reserved to those cases who remained undiagnosed
after the 4-week external monitoring.
† In patients with unexplained palpitation, the 4-week external
ECG monitoring can be considered as first-line diagnostic
tool, providing a conclusive diagnosis in most cases, avoiding use-
less repetition of standard 24 h Holter monitoring, with longer
monitoring by ILR would be required only in few selected cases.
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† Negative monitorings: (i) monitorings without event recurrence reported
in the patient diary and without recording of asymptomatic arrhythmia
by auto-trigger function; (ii) monitorings with recurrence of symptoms
different from the index event; and (iii) monitorings with recurrence of
syncope or palpitations, but without available ECG recording.
Statistical analysis
All analyses were performed on the intention-to-treat (ITT) popu-
lation, both overall and separately per index event (syncope or
palpitations). Since the distribution of the data was normal, continu-
ous data were expressed as mean+ standard deviation (SD), while
categorical variables as frequencies and percentages and differences
in categorical variables were tested by x2 test or by Fisher exact test
as appropriate.
The time-to-first occurrence of a diagnostic event during 4-week
monitoring was analysed by Kaplan–Meier survival analysis, and sur-
vival curves of patients with syncope and palpitations were com-
pared by log-rank test. Actuarial diagnostic yields for diagnostic
events were retrieved from Kaplan–Meier statistics and compared
by x2 analysis when applicable.
Predictors of occurrence of diagnostic events during the 4-week
monitoring were identified by multivariable Cox proportional-
hazard model, after proportional-hazard assumptions were verified.
A stepwise procedure was applied: first, univariable analyses deter-
mined statistically significant variables at 20%, and then significant
variables were introduced in the multivariable model.
Two-sided P values of ,0.05 were considered significant in all
evaluations. Analyses were performed using SAS software release
9.2 (SAS Institute, Cary, NC, USA).
Results
Study population
The SYNARR-Flash study enrolled 395 patients (42.3% males, age
56.9+ 18.7 years) from 10 centres in five countries between
August 2010 and June 2013. As index event information was unavail-
able for three patients, the ITT population included 392 patients;
282 patients (71.9%) enrolled for palpitations and 110 (28.1%) for
syncope.
Patients with syncope were older, more frequently males, with
previous history of cardiovascular disease, family history of sudden
death, hypertension, and use of cardiovascular medication (Table 1).
Previous diagnostic tests, when available, were reported negative in
all patients.
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Table 1 Demographic characteristics
Parameters (number, %) ITT population with syncope
n 5 110




Age, mean (+SD) 65.1 (+17.2) 53.9 (+18.4) ,0.001
Male gender 64 (59.3%) 101 (35.8%) ,0.001
NYHA, n 68 191
I/II 66 (97.1%) 190 (99.5%) 0.170
III/IV 2 (2.9%) 1 (0.5%)
Previous diagnosis test, n 106 262
24 h Holter recording 64 (60.4%) 159 (60.7%) 0.956
HUT 21 (19.8%) 13 (5.0%) ,0.001
CSM 27 (25.5%) 10 (3.8%) ,0.001
Exercise stress test 12 (11.3%) 41 (15.6%) 0.284
History of previous rhythm disorders
Supraventricular rhythm disorders
a
40 (57.1%) 103 (66.0%) 0.200
AV conduction disorders
b
32 (45.7%) 63 (40.4%) 0.453
Ventricular rhythm disorders
c
29 (41.4%) 65 (41.7%) 0.973
History of cardiovascular disease, n 70 155
Systemic hypertension 41 (58.6%) 68 (43.9%) 0.041
Coronary artery disease 8 (11.4%) 12 (7.7%) 0.368
Cerebrovascular accident 8 (11.4%) 7 (4.5%) 0.054
Ischaemic cardiomyopathy 5 (7.1%) 9 (5.8%) 0.701
Previous myocardial infarction 3 (4.3%) 6 (3.9%) 1.000
Family history of sudden cardiac death 9 (8.2%) 7 (2.5%) 0.006
Cardiovascular medication at the time of the test 82 (74.5%) 190 (67.4%) 0.166
SD, standard deviation; NYHA, New York Heart Association functional class; AV, atrio-ventricular.
aIncludes sinus arrest/pauses ,3 s, sinus bradycardia .40 b.p.m., sinus tachycardia, paroxysmal AF, frequent PACs (.10/min), chronic AF, and paroxysmal atrial flutter/
tachycardia.
bIncludes AVB I, AVB II Mobitz 1, LBBB, and RBBB.
cInclude frequent PVCS (.10/min), couplets, and non-sustained VT.
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Duration of ECG monitoring
The mean duration of ECG monitoring was 23.0+8.1 days, similar
for syncope and palpitations. In 22 patients, the recording was
stopped for the occurrence of a major event. In four patients
(1%), the recording was interrupted due to intolerance to electro-
des, while two patients (0.5%) withdrew from the study. Skin reac-
tions to electrodes were reported in 12 patients (3%), but all were
defined as non-serious and solved spontaneously.
Findings in patients with syncope
Twenty-seven patients with prior syncope (24.5%) had a diagnos-
tic event within the 4-week monitoring. Conclusive events with
ECG-documented syncope occurred in 11 patients (10%, Table 2):
in 6 patients, supraventricular bradyarrhythmias were recorded
during syncope, while in 5 cases, regular sinus rhythm or sinus
tachycardia was recorded (Table 2). Auto-trigger function identi-
fied asymptomatic significant arrhythmias in 16 patients (14.5%,
Table 2).
The actuarial diagnostic yield, calculated by the Kaplan–Meier cu-
mulative occurrence of diagnostic events, was 13.2% at 1 week,
19.1% at 2 weeks, and 29.4% at 4 weeks (Figure 1).
Auto-trigger function detected asymptomatic suggestive arrhyth-
mias in 10 patients (9.1%, Table 2), although per definition were not
included as diagnostic events. The cumulative yield including con-
clusive, significant, and suggestive events would be 33.6%.
Multivariable analyses to identify potential predictors of diagnos-
tic events included age, gender, previous recording of supraventricu-
lar or ventricular arrhythmia, time from index event to enrolment
(0–15 days vs..15 days after index syncope), the number of events
in preceding year, history of cardiovascular disease, and family his-
tory of sudden cardiac death. The only two significant predictors
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Table 2 Electrocardiogram findings during monitoring in patients with syncope and palpitation
Patients Syncope (n 5 110) Palpitation (n 5 282)
n % n %
Diagnostic tests 27 24.5 202 71.6
Conclusive events (recurrence reported on patient diary) 11 10.0 193 68.4
Non-arrhythmic (sinus rhythm, sinus tachycardia) 5 4.5 66 23.4
Arrhythmic 6 5.5 127 45.0
Pauses (≥6 s), AVB 3 or AVB 2 Mobitz 2 4 3.6 1 0.4
Pauses (3–6 s), sinus bradycardia 2 1.8 7 2.5
Paroxysmal AF, AFL (.3 min) 0 0.0 22 7.8
Paroxysmal SVT (.3 min) 0 0.0 15 5.3
Non-sustained SVT (15 s–3 min) 0 0.0 40 14.2
NSVT ,10 s 0 0.0 5 1.8
NSVT .10 s 0 0.0 1 0.4
Frequent VPBs or APBs 0 0.0 36 12.7
Asymptomatic significant arrhythmias 16 14.5 9 3.2
Fast sustained AF/AFL/SVT .3 min .180 b.p.m. 8 7.3 8 2.8
Sinus bradycardia ,30 b.p.m., Pauses ≥6 s, AVB 3 or AVB 2 Mobitz 2 5 4.5 1 0.4
NSVT .10 s or sustained ventricular tachycardia .30 s 3 2.7 0 0.0
Non-diagnostic tests 83 75.5 80 28.4
Negative monitoring 73 66.4 59 20.9
Asymptomatic suggestive arrhythmias 10 9.1 21 7.5
Sinus bradycardia 30–40 b.p.m., sinus pauses 3–6 s 5 4.5 11 3.9
NSVT ,10 s 5 4.5 9 3.2
AF/AFL/SVT 15 s–3 min 0 0.0 1 0.4
AVB 2, AVB 3, atrio-ventricular block (Grade 2 or 3); AF, atrial fibrillation; AFL, atrial flutter; SVT, supraventricular tachycardia; NSVT, non-sustained ventricular tachycardia; VPBs,
ventricular premature beats; APBs, atrial premature beats.
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Time to first diagnosed event (days)
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Figure 1 Kaplan–Meier analysis of recurrence-free rate in pa-
tients with syncope (continuous line) and palpitations (dashed
line) of first diagnostic event during prolonged ECG monitoring
(log rank: P, 0.001).
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for diagnostic findings during the 4-week monitoring were (i) early
start of monitoring after index event and (ii) previous history of
supraventricular arrhythmias [sinus arrest or pauses ,3 s, sinus
bradycardia .40 b.p.m., sinus tachycardia .100 b.p.m., paroxysmal
AF, frequent PACs (.10/min), chronic AF, paroxysmal atrial flutter/
tachycardia—Table 3]. Monitoring was started within 15 days from
index event in 74 patients: 4-week actuarial diagnostic yield was
33.0% in patients with early initiation compared with 15.6% in later
initiation (P ¼ 0.021, Figure 2A). History of supraventricular arrhyth-
mias was present in 39 patients: 4-week actuarial diagnostic yield
was 43.6% in patients with supraventricular arrhythmias compared
with 21.3% in those without (P ¼ 0.018, Figure 2B).
Findings in patients with palpitations
A total of 202 patients (71.6%) had a diagnostic event within the
4-week monitoring (Table 2). Conclusive events occurred in 193 pa-
tients (68.4%). Sinus rhythm or sinus tachycardia was present at
patient-activated recording during palpitation in about two-thirds of
the cases, while SVT, AF or AFL, bradycardia, pauses or NSVT were
present in the remaining cases. Significant asymptomatic arrhythmias
were detected by auto-trigger function in nine patients (3.2%).
Asymptomatic suggestive arrhythmias were detected by auto-
trigger function in 21 patients (7.5%, Table 2), which per definition
were not included as diagnostic events. The cumulative yield includ-
ing conclusive, significant, and suggestive events would be 79.1%.
The Kaplan–Meier cumulative occurrence of diagnostic events was
42.4% at 1 week, 57.2% at 2 weeks, and 77.0% at 4 weeks (Figure 1).
Previous frequent palpitations and early start of recording after
the index event were significant predictors of diagnostic events
(Table 3).
The diagnostic yield progressively increased with the number of
palpitations during the year preceding the enrolment (Figure 3A).
The diagnostic yield was 46.2% in patients with 1 or no palpitation,
68.1% in patients with 2–5 palpitations, 76.7% in patients with 6–10
palpitations, and 83.1% in patients with ≥11 palpitations (Figure 3A).
The 4-week diagnostic yield was higher in patients starting the
recording 0–7 days after the index event (Table 3, Figure 3B).
Discussion
The SYNARR-Flash study is the first international, multicentre, obser-
vational, prospective trial designed to prove the feasibility and
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Table 3 Predictors for diagnosis during the 4-week ECG monitoring
Variables P-value Odds ratio 95% Wald
confidence
limits
A—patients studied for syncope
Time between index event and enrolment 0–15 days vs. .15 days 0.021 6.2 1.3 29.6
History of supraventricular arrhythmiasa Yes vs. No 0.018 3.6 1.4 9.7
B—patients studied for palpitations
History of previous palpitations (in the previous 12 months) 2–5 vs. ≤1 0.036 2.6 1.1 6.3
6–10 vs. ≤1 0.029 2.8 1.1 7.3
≥11 vs. ≤1 ,0.001 4.3 2.0 9.4
Time between index event and enrolment 0–7 days vs. 8–15 days 0.004 3.0 1.4 6.4
0–7 days vs. .15 days 0.031 2.3 1.1 4.9







Log rank: P = 0.021
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Time to first diagnosed event (days)
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Figure 2 (A) Kaplan–Meier analysis of recurrence-free rate in pa-
tients with syncope enrolled at 0–15 days after the index syncope
(continuous line) vs..15 days after the index syncope (dashed line),
OR¼ 6.222, 95% CI (1.309–29.573), P ¼ 0.02 (see Table 3 for de-
tails). (B) Kaplan–Meier analysis of recurrence-free rate in patients
with syncope without previous history of supraventricular rhythm
disorder (continuous line) vs. patients with previous history of su-
praventricular rhythm disorder (dashed line), OR¼ 3.631, 95% CI
(1.356–9.724), P ¼ 0.01 (see Table 3 for details).
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usefulness of external prolonged ECG monitoring in early clinical
work-up of unexplained syncope and/or sustained palpitations of
suspected arrhythmic origin. In unexplained syncope, prolonged
external ECG monitoring achieved a diagnosis in about one-third
of the patients, and most diagnoses occurred in those who started
the monitoring within 15 days from index syncope (Figure 2A) and
in those with history of SVT (Figure 2B). These findings suggest two
new clinical criteria in order to increase the diagnostic likelihood in
unexplained syncope, namely early initiation of monitoring after
an event and previous history of supraventricular arrhythmias.
In unexplained palpitations, the 4-week actuarial diagnostic yield
was 77.0%, increasing up to 81.3% in patients with previous fre-
quent palpitations (Figure 3A), supporting its utility as first-line diag-
nostic tool in palpitation work-up.
Prolonged external ECG monitoring
in unexplained syncope
All enrolled patients had unexplained syncope of suspected arrhyth-
mic origin according to the criteria outlined in 2009 Guidelines for
diagnosis and management of syncope.1 In this study, the actuarial
diagnostic yield of the 4-week ECG monitoring was 29.4%, higher
than the 1–10% diagnostic yield generally reported for 24 h Holter
recording, and consistent with previous studies utilizing external
long-term ECG monitoring, reporting diagnostic yields of 15–20%
at 1 month.11–15,19
In our study, the 4-week diagnostic yield for syncope was similar
or higher than in studies using ILR, when considering a similar mon-
itoring period. In the PICTURE registry,9 the 3-month diagnostic
yield was 19%, and in most studies, the diagnostic yield of ILR ranged
from 30 up to 50%,7 –10 indicating that syncope often remained un-
explained even after 3-year ILR monitoring. These data support the
concept that diagnostic findings in most patients with unexplained
syncope occur relatively early after an index event, making pro-
longed external ECG monitoring sufficient to obtain a clinical diag-
nosis in most cases, with only a few selected patients requiring a
much longer monitoring period.
In our study, arrhythmias were documented during syncope in
about half of the patients, typically bradycardia or pauses leading
to pacemaker implant, while in the remaining cases, no arrhythmias
were detected, excluding an arrhythmic origin of syncope. These pa-
tients should then be referred for further clinical evaluation, possibly
including carotid sinus massage (CSM) or head-up tilt test (HUT) or
neurological work-up, while further prolonged ECG monitoring is
not necessary.
Asymptomatic arrhythmias predefined as significant were de-
tected by auto-trigger function in 16 patients (14.5%, Table 2). Sig-
nificant arrhythmias were considered diagnostic even in the absence
of recurrent syncope following the 2009 Syncope Guidelines, with
evidence Class 1 Level C.1 This classification was specifically pro-
posed by the International Study on Syncope of Unknown Etiology
(ISSUE) investigators, with the aim to group the observations from
prolonged ECG monitoring into homogeneous patterns in order to
define an acceptable standard useful for future studies and clinical
practice.20 Of note, this classification has been utilized in most
studies with ILR, where unsuspected asymptomatic arrhythmias in
the absence of syncope were generally considered diagnostic
findings.7– 10
To avoid potential bias, for this study, we utilized more stringent
criteria for definition of significant asymptomatic arrhythmias than
those proposed by the 2009 Syncope Guidelines. Asymptomatic
suggestive arrhythmias were detected in 9.1% of patients (Table 2),
which per definition were not included in the diagnostic yield,
although some of these arrhythmias, such as 3–6 s pauses, would
have been considered diagnostic according to 2009 Syncope
Guidelines.1,20 Patients with asymptomatic suggestive arrhythmias
seem to be the ideal candidates to continue prolonged ECG mon-
itoring by ILR, to confirm or exclude the presence of significant
arrhythmias.
In syncope, early initiation of recording after an index event
was a significant predictor of diagnosis during the 4-week moni-
toring (Figure 2A). This is consistent with some preliminary obser-
vations suggesting that syncopal events occur in clusters,10 making
it crucial to initiate the monitoring as soon as possible after an
event.
A second significant predictor of diagnostic events was history of
supraventricular arrhythmias, suggesting that patients with previous
paroxysmal AF are reasonable candidates to prolonged ECG mon-
itoring after an unexplained syncope. Of note, AF was not included
among ECG criteria suggesting an arrhythmic origin for unexplained
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Figure 3 (A) Kaplan–Meier analysis of recurrence-free rate in
patients with palpitations according to the previous number of
events in the last 12 months (see Table 3 for details). (B) Ka-
plan–Meier analysis of recurrence-free rate in patients with palpi-
tations according to the time between index event and enrolment
(see Table 3 for details).
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Prolonged external ECG monitoring
in unexplained palpitations
In patients with unexplained sustained palpitations, the diagnostic
yield of external monitoring was 42.4% at 1 week, 57.2% at 2 weeks,
and 71.6% at 4 weeks. These data are consistent with previous stud-
ies,5,15,20,21 making the 4-week external ECG monitoring the first-
choice tool in the diagnostic workflow of unexplained palpitations.
Only patients with palpitations remaining unexplained after the
4-week monitoring may require further observation, either by
ILR21 or by event recorders.22
The diagnostic yield was 50% at 1 week and 70% at 2 weeks in
patients with previous frequent palpitations (Figure 3A) or in patients
studied early after an index event (Figure 3B). These data support the
utility of 1-week and 2-week external recordings, especially when
utilized in high-risk patients and started early after an event.
Sinus rhythm or sinus tachycardia, or short episodes of SVT were
observed during palpitations in most patients, while sustained and
fast SVT, AF, or AFL were documented in 13% of the cases (Table 2).
In fewer cases, sinus bradycardia and pauses were observed, often
associated with dizziness or presyncope, besides palpitations. The
clinical significance or the clinical management of such findings
was beyond the scope of this study.
Although the main objective of prolonged external ECG moni-
toring was to correlate symptoms and arrhythmias, asymptomatic
paroxysmal AF (either brief or sustained episodes) was detected
in 10% of the patients with unexplained palpitations. These find-
ings support the discrepancy between perceived symptoms and
documented arrhythmias, and confirm that silent AF is relatively
frequent even in patients with history of palpitations.4,5,16,17
Study limitations
One possible limitation was that not all centres contributed with the
same amounts of patients, as three centres (Valld’Hebron, Milan,
and Lavagna) enrolled 75% of the patients. However, no signifi-
cant differences were observed among patients enrolled by the
different centres.
The information provided in patients’ diary was used to cat-
egorize for the absence or presence and kind of symptom (syn-
cope or palpitation) at the time of arrhythmias. It is impossible
to verify the accuracy of events reported in the diary by each pa-
tient, although the diary information was cross-checked at M1
clinic visits.
Predefined criteria were utilized to distinguish between ‘significant’
and ‘suggestive’ asymptomatic arrhythmias detected by auto-trigger
function, based on recommendation from current guidelines1,20 and
on our best clinical judgement. Due to lack of consensus on the min-
imum duration required to define an episode of paroxysmal AF,4,5 we
utilized a restrictive criteria (duration .180 s) for significant events,
while shorter events were only considered suggestive. Although the
presence of fast and sustained supraventricular arrhythmias may sug-
gest a syncope of arrhythmic origin, the precise mechanism provoking
the syncope in the individual patient remains unknown, and the attri-
bution of a specific aetiology for syncope in the individual patients is
beyond the scope of this study. More stringent criteria were used also
for pauses and NSVT, although some suggestive asymptomatic ar-
rhythmias may represent meaningful findings in the diagnostic
workflow and would have been considered diagnostic according to
the 2009 Syncope Guidelines.1,20
Information about previous diagnostic tests, specifically CSM and
HUT, was collected wherever available, but it was beyond the
power of this study to verify why a specific diagnostic test was per-
formed or not performed in the single patient. This study population
was too small to draw any definitive conclusion on the possible cor-
relation between ELR-negative and HUT-negative findings.
The cumulative diagnostic yield observed in this study both for
syncope and palpitation may be an overestimation of the true clinical
benefit. The capability of prolonged early monitoring to influence
therapeutic decisions or to improve clinical outcomes was beyond




The early use of external 4-week ECG recorders in unexplained
syncope of suspected arrhythmic origin proved to be a feasible
‘stepwise’ strategy, starting the recording as soon as possible after
an event in order to maximize the diagnostic yield of external ECG
monitoring. In patients with unexplained syncope of suspected ar-
rhythmic origin, in whom prolonged ECG monitoring is consid-
ered appropriate according to current guidelines, the 4-week
external ECG monitoring should be utilized as first step, while
more expensive and minimally invasive ILR should be reserved
to those cases who remained undiagnosed after the 4-week exter-
nal monitoring. In patients with unexplained palpitation, the
4-week external ECG monitoring can be considered as first-line
diagnostic tool, providing a conclusive diagnosis in most cases,
avoiding useless repetition of standard 24 h Holter monitoring,
with longer monitoring by ILR would be required only in a few se-
lected cases.22 – 25
The results of this study, which utilized external loop recording
with auto-trigger function, may be extended to new systems of
long-lasting external ECG recordings providing continuous ECG
monitoring,21 that may have an even higher capability of detecting
asymptomatic arrhythmias.
In patients with unexplained palpitation, the 4-week external
ECG monitoring can be considered as first-line diagnostic tool, pro-
viding a conclusive diagnosis in most cases, avoiding useless repeti-
tion of standard 24 h Holter monitoring, with longer monitoring by
ILR required only in few selected cases.
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